186 related articles for article (PubMed ID: 32249544)
1. Therapeutic Effects of Anti-Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor Treatment in Psoriasis and Arthritis.
Alvarez P; Augustín JJ; Tamayo E; Iglesias M; Acinas O; Mendiguren MA; Vázquez JA; Genre F; San Segundo D; Merino J; Merino R
Arthritis Rheumatol; 2020 Sep; 72(9):1547-1558. PubMed ID: 32249544
[TBL] [Abstract][Full Text] [Related]
2. Bone Morphogenetic Protein and Activin Membrane-Bound Inhibitor, a Transforming Growth Factor β Rheostat That Controls Murine Treg Cell/Th17 Cell Differentiation and the Development of Autoimmune Arthritis by Reducing Interleukin-2 Signaling.
Postigo J; Iglesias M; Álvarez P; Jesús Augustin J; Buelta L; Merino J; Merino R
Arthritis Rheumatol; 2016 Jun; 68(6):1551-62. PubMed ID: 26714180
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
4. Collagen-induced arthritis and imiquimod-induced psoriasis develop independently of interleukin-33.
Athari SK; Poirier E; Biton J; Semerano L; Hervé R; Raffaillac A; Lemeiter D; Herbelin A; Girard JP; Caux F; Boissier MC; Bessis N
Arthritis Res Ther; 2016 Jun; 18(1):143. PubMed ID: 27317338
[TBL] [Abstract][Full Text] [Related]
5. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
[TBL] [Abstract][Full Text] [Related]
6. Novel therapeutic compound tuftsin-phosphorylcholine attenuates collagen-induced arthritis.
Bashi T; Shovman O; Fridkin M; Volkov A; Barshack I; Blank M; Shoenfeld Y
Clin Exp Immunol; 2016 Apr; 184(1):19-28. PubMed ID: 26618631
[TBL] [Abstract][Full Text] [Related]
7. Cytokine-induced alterations of BAMBI mediate the reciprocal regulation of human Th17/Treg cells in response to cigarette smoke extract.
Liu HJ; Chen G; Chen L; Zhou M; Xiong XZ; Meng ZJ; Sun SW; Tao XN
Int J Mol Med; 2018 Dec; 42(6):3404-3414. PubMed ID: 30320351
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment.
Bonnefoy F; Couturier M; Clauzon A; Rémy-Martin JP; Gaugler B; Tiberghien P; Chen W; Saas P; Perruche S
J Immunol; 2011 Jun; 186(11):6157-64. PubMed ID: 21518970
[TBL] [Abstract][Full Text] [Related]
9. Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance.
Kong N; Lan Q; Chen M; Wang J; Shi W; Horwitz DA; Quesniaux V; Ryffel B; Liu Z; Brand D; Zou H; Zheng SG
Arthritis Rheum; 2012 Aug; 64(8):2548-58. PubMed ID: 22605463
[TBL] [Abstract][Full Text] [Related]
10. L161982 alleviates collagen-induced arthritis in mice by increasing Treg cells and down-regulating Interleukin-17 and monocyte-chemoattractant protein-1 levels.
Chen L; Wu X; Zhong J; Li D
BMC Musculoskelet Disord; 2017 Nov; 18(1):462. PubMed ID: 29145862
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
12. Kaempferol attenuates imiquimod-induced psoriatic skin inflammation in a mouse model.
Liu C; Liu H; Lu C; Deng J; Yan Y; Chen H; Wang Y; Liang CL; Wei J; Han L; Dai Z
Clin Exp Immunol; 2019 Dec; 198(3):403-415. PubMed ID: 31407330
[TBL] [Abstract][Full Text] [Related]
13. A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes.
Shin SH; Kim HY; Yoon HS; Park WJ; Adams DR; Pyne NJ; Pyne S; Park JW
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171607
[TBL] [Abstract][Full Text] [Related]
14. IL-2-Anti-IL-2 Monoclonal Antibody Immune Complexes Inhibit Collagen-Induced Arthritis by Augmenting Regulatory T Cell Functions.
Yokoyama Y; Iwasaki T; Kitano S; Satake A; Nomura S; Furukawa T; Matsui K; Sano H
J Immunol; 2018 Oct; 201(7):1899-1906. PubMed ID: 30143591
[TBL] [Abstract][Full Text] [Related]
15. A mouse model of adoptive immunotherapeutic targeting of autoimmune arthritis using allo-tolerogenic dendritic cells.
Yang J; Yang Y; Ren Y; Xie R; Zou H; Fan H
PLoS One; 2013; 8(10):e77729. PubMed ID: 24204938
[TBL] [Abstract][Full Text] [Related]
16. ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis.
Notley CA; McCann FE; Inglis JJ; Williams RO
Arthritis Rheum; 2010 Jan; 62(1):171-8. PubMed ID: 20039431
[TBL] [Abstract][Full Text] [Related]
17. Targeting of Phospholipase D1 Ameliorates Collagen-Induced Arthritis via Modulation of Treg and Th17 Cell Imbalance and Suppression of Osteoclastogenesis.
Yoo HJ; Hwang WC; Min DS
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370217
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic inhibition of RORγt regulates Th17 signature gene expression and suppresses cutaneous inflammation in vivo.
Skepner J; Ramesh R; Trocha M; Schmidt D; Baloglu E; Lobera M; Carlson T; Hill J; Orband-Miller LA; Barnes A; Boudjelal M; Sundrud M; Ghosh S; Yang J
J Immunol; 2014 Mar; 192(6):2564-75. PubMed ID: 24516202
[TBL] [Abstract][Full Text] [Related]
19. [Zaocys type II collagen regulates mesenteric lymph node Treg/Th17 cell balance in mice with collagen-induced arthritis].
Wang H; Feng Z; Zhu J; Li J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 May; 34(5):622-6. PubMed ID: 24849423
[TBL] [Abstract][Full Text] [Related]
20. Selective Activation of Tumor Necrosis Factor Receptor II Induces Antiinflammatory Responses and Alleviates Experimental Arthritis.
Fischer R; Proske M; Duffey M; Stangl H; Martinez GF; Peters N; Kraske A; Straub RH; Bethea JR; Kontermann RE; Pfizenmaier K
Arthritis Rheumatol; 2018 May; 70(5):722-735. PubMed ID: 29342501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
